Spire Healthcare Group PLC (LON:SPI) hit a new 52-week low during trading on Wednesday . The company traded as low as GBX 218.20 ($3.01) and last traded at GBX 219.20 ($3.03), with a volume of 990964 shares changing hands. The stock had previously closed at GBX 224 ($3.09).
A number of equities research analysts have recently commented on the company. Barclays assumed coverage on Spire Healthcare Group in a research report on Friday, February 2nd. They issued an “equal weight” rating and a GBX 270 ($3.73) price objective for the company. Liberum Capital lifted their price objective on Spire Healthcare Group from GBX 270 ($3.73) to GBX 275 ($3.80) and gave the company a “hold” rating in a research report on Friday, January 26th. Numis Securities reaffirmed an “add” rating and issued a GBX 296 ($4.09) price objective on shares of Spire Healthcare Group in a research report on Tuesday, January 16th. JPMorgan Chase & Co. reaffirmed a “neutral” rating and issued a GBX 339 ($4.68) price objective on shares of Spire Healthcare Group in a research report on Thursday, January 4th. Finally, Jefferies Group raised Spire Healthcare Group to a “buy” rating and lifted their price objective for the company from GBX 259 ($3.58) to GBX 290 ($4.01) in a research report on Wednesday, January 17th. One research analyst has rated the stock with a sell rating, five have given a hold rating and two have assigned a buy rating to the stock. The company has an average rating of “Hold” and an average target price of GBX 304.29 ($4.20).
The stock has a market capitalization of $885.59 and a PE ratio of 3,131.43.
In related news, insider Justin Ash acquired 84,500 shares of Spire Healthcare Group stock in a transaction on Thursday, November 23rd. The shares were bought at an average price of GBX 237 ($3.27) per share, for a total transaction of £200,265 ($276,685.55). Also, insider Peter R. Bamford acquired 5,000 shares of Spire Healthcare Group stock in a transaction on Monday, November 27th. The shares were bought at an average price of GBX 240 ($3.32) per share, for a total transaction of £12,000 ($16,579.17).
ILLEGAL ACTIVITY WARNING: This news story was published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this news story on another domain, it was stolen and reposted in violation of United States & international trademark and copyright law. The original version of this news story can be viewed at https://www.dispatchtribunal.com/2018/02/14/spire-healthcare-group-spi-sets-new-12-month-low-at-218-20.html.
Spire Healthcare Group Company Profile
Spire Healthcare Group plc is a United Kingdom-based independent hospital group. The Company provides in-patient, daycase and out-patient care from approximately 40 hospitals, 10 clinics and over two specialist care centers across the United Kingdom. The Company also owns and operates a sports medicine, physiotherapy and rehabilitation brand, Perform, and a screening service, Lifescan, as well as national pathology services.
Receive News & Ratings for Spire Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.